Our partners

Launched in 2016, IDDO builds on and incorporates the pioneering work of the WorldWide Antimalarial Resistance Network (WWARN), a collaborative data-sharing framework begun in 2009 that proved it was possible to produce policy-changing scientific evidence from historical data.

Find out more about our currently active areas of research below:

Our visceral leishmaniasis partners
VL collaborator map

IDDO is collaborating globally with many partners to collate data and deliver evidence to address knowledge gaps and accelerate treatments for visceral leishmaniasis (VL).
Our Chagas partners
istock

IDDO brings together a broad range of expertise from across the infectious diseases research community. Below are the team members working on the Chagas Disease research theme based at IDDO. The theme is coordinated by IDDO and the Drugs for Neglected Diseases initiative’s Latin America Office.
Our Ebola partners
Medical staff

The Ebola Data Platform brings together data for the health, research and humanitarian communities to strengthen capacity and accelerate research that reduces the impact of Ebola.
Our Medicine Quality Research Group partners
pills

Substandard and falsified (SF) medicines negate the multiple benefits of modern healthcare, so good quality medical products are essential. By sharing global expertise and collating information, IDDO’s Medicine Quality Research Group strengthens knowledge of the scale of the problem and raises vital awareness among key stakeholders.